Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hepatitis C 1Hepatitis 1Carcinoma, Hepatocellular 1Bronchiolitis Obliterans Syndrome 1

Interventions

tofacitinib 7ibrutinib 6ruxolitinib 3ofatumumab 3asciminib 3Imatinib Mesylate 3Dasatinib 3nilotinib 2bosutinib 2Rituximab 2Oxycodone 2Naloxone 2KW-2478 2sodium luminolate 1oblimersen 1obinutuzumab 1mocetinostat 1milatuzumab 1ixekizumab 1fenebrutinib 1canakinumab 1belumosudil 1baricitinib 1axatilimab 1abexinostat 1Vision, Ocular 1Sofosbuvir 1Sirolimus 1Saline Solution 1Ribavirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Bronchiolitis Obliterans Syndrome × Sofosbuvir × Clear all
NCT01559844 2016-07-27

Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant

Gilead Sciences

Phase 2 Completed
61 enrolled 25 charts
Gastrointestinal

Bronchiolitis Obliterans Syndrome, Hepatitis, Hepatitis C, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡